Your browser doesn't support javascript.
loading
Clinical Trial Assessment of Infrastructure Matrix Tool to Improve the Quality of Research Conduct in the Community.
Dimond, Eileen P; Zon, Robin T; Weiner, Bryan J; St Germain, Diane; Denicoff, Andrea M; Dempsey, Kandie; Carrigan, Angela C; Teal, Randall W; Good, Marjorie J; McCaskill-Stevens, Worta; Grubbs, Stephen S; Dimond, Eileen P; Zon, Robin T; Weiner, Bryan J; St Germain, Diane; Denicoff, Andrea M; Dempsey, Kandie; Carrigan, Angela C; Teal, Randall W; Good, Marjorie J; McCaskill-Stevens, Worta; Grubbs, Stephen S.
Afiliação
  • Dimond EP; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
  • Zon RT; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
  • Weiner BJ; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
  • St Germain D; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
  • Denicoff AM; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
  • Dempsey K; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
  • Carrigan AC; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
  • Teal RW; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
  • Good MJ; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
  • McCaskill-Stevens W; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
  • Grubbs SS; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
  • Dimond EP; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
  • Zon RT; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
  • Weiner BJ; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
  • St Germain D; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
  • Denicoff AM; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
  • Dempsey K; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
  • Carrigan AC; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
  • Teal RW; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
  • Good MJ; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
  • McCaskill-Stevens W; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
  • Grubbs SS; Michiana Hematology Oncology, South Bend, IN; University of North Carolina (UNC) Chapel Hill; UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC; National Cancer Institute, Bethesda; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD; and Helen F. G
J Oncol Pract ; 12(1): 63-4, e23-35, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26627979
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Garantia da Qualidade dos Cuidados de Saúde / Qualidade da Assistência à Saúde / Pesquisa Biomédica / Melhoria de Qualidade / Estudos Clínicos como Assunto Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: J Oncol Pract Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Garantia da Qualidade dos Cuidados de Saúde / Qualidade da Assistência à Saúde / Pesquisa Biomédica / Melhoria de Qualidade / Estudos Clínicos como Assunto Tipo de estudo: Guideline / Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: J Oncol Pract Ano de publicação: 2016 Tipo de documento: Article